The Health Benefits of Walking as a Method of Disease Prevention and Increasing Human Life Expectancy
Keywords:
physical activity, walking, locomotion, disease prevention, ageing, life expectancyAbstract
The article is devoted to the health-improving value of walking as a method of disease prevention to increase human life expectancy. It is shown that moderate physical activity in the form of dosed walking helps prevent many diseases.
Scientific and technological progress leads to a decrease in human motor activity, which leads to an increase in the number of diseases associated with hypokinesia. The resulting deficit in motor activity can be compensated for by a natural method of physical activity - walking. Walking is available to everyone, regardless of age or living conditions. Walking is the most common type of locomotion, the purpose of which is human movement. Walking involves the entire human musculoskeletal system, and the main force ¬that ensures body movement is muscle strength. Dosed walking is the most common means of preventive and restorative medicine. Moderate physical activity in the form of dosed walking helps prevent many diseases. It has a positive effect on the course of cardiorespiratory diseases, immunity, the state of the gastrointestinal tract and musculoskeletal system, reduces the risk of cancer, improves the quality and duration of life. According to recommendations, people under 20 years of age should have regular aerobic exercise on average 4 times a week and for at least 30 minutes. The WHO strategy on staying active in old age aims to achieve the highest level of health and well-being for older people and older adults by increasing their daily physical activity.
References
Madjidova G. T., Sunnatova G. I., Hamidov N. S. CLINICAL AND HEMODYNAMIC CONDITIONS AND HEART NATRIURETIC PEPTIDES IN THE BLOOD PLASMA OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY //Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 5. – С. 211-219.
Khasanjanova F. O. et al. Evaluation of the effectiveness of thrombolytic therapy in men with acute coronary myocardial infarction in young age //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2021. – Т. 2. – №. 1. – С. 144-149.
Khasanzhanova F. O. et al. EVALUATION OF THE EFFECTIVENESS OF THROMBOLYTIC THERAPY IN MEN WITH ACUTE MYOCARDIAL INFARCTION IN YOUNG AGE //Archive of Conferences. – 2021. – Т. 15. – №. 1. – С. 48-52.
Madjidova G. T., Sunnatova G. I., Usarov S. A. ABOUT THE SYSTEM OF TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME //Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 5. – С. 197-204.
Alisherovna S. N. et al. Course of Myocardial Infarction in Young Women //Eurasian Medical Research Periodical. – 2022. – Т. 7. – С. 106-111.
Samadova N. A. et al. Clinical and Diagnostic Features of Myocardial Infarction in Young Patients in Emergency Medicine //E-Conference Globe. – 2021. – С. 16-19.
Alisherovna S. N. et al. CLINICAL AND DIAGNOSTIC FEATURES OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS IN EMERGENCY MEDICINE //Web of Scientist: International Scientific Research Journal. – 2021. – Т. 2. – №. 04. – С. 414-418.
Самадова Н. и др. SHOSHILINCH TIBBIY YORDAMDA YOSH BEMORLARDA MIOKARD INFARKTINING KLINIK VA DIAGNOSTIK XUSUSIYATLARI //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 1. – С. 78-81.
Alisherovna S. N. et al. A Modern Approach to Risk Stratification in Patients with Heart Failure with Preserved and Reduced Ejection Fraction //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 5. – С. 73-81.
Alisherovna S. N. et al. FEATURES OF THE CLINICAL COURSE OF UNSTABLE ANGINA ON THE BACKGROUND OF COPD //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 5. – С. 82-86.
Alisherovna S. N. et al. FEATURES OF THE CLINICAL COURSE OF UNSTABLE ANGINA ON THE BACKGROUND OF COPD //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 5. – С. 82-86.
Тогаева Б. и др. COVID-19 YURAK QON TOMIR KASALLIKLARI BOR BEMORLARDA KECHISHI //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 2. – С. 47-50.
Ташкенбаева Э. и др. РАСПРОСТРАНЕННОСТЬ МЕТАБОЛИЧЕСКОГО СИНДРОМА У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 1. – С. 85-88.
Togaeva B. et al. OCCURRENCE OF SARS–COV-2 DISEASE (COVID-19) AND IN PATIENTS WITH CARDIOVASCULAR DISEASES //InterConf. – 2021.
ХАСАНЖАНОВА Ф., ТАШКЕНБАЕВА Э., ХАЙДАРОВА Д. РОЛЬ ГЕНА IL-1β 3953 C/T ПРИ РАЗВИТИИ НЕСТАБИЛЬНЫХ ВАРИАНТОВ СТЕНОКАРДИИ У МУЖЧИН В МОЛОДОМ ВОЗРАСТЕ В ЗАВИСИМОСТИ ОТ ЦИТОКИНОВОГО СТАТУСА //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 4. – С. 63-66.
